Concord Medical Services Holdings Stock-Based Compensation Growth & History (CCM)
Concord Medical Services Holdings's stock-based compensation was −$858,000 for fiscal 2022.
View full Concord Medical Services Holdings company overviewConcord Medical Services Holdings annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2022 | 2022-12-31 | −$858,000 | −$3.2M | — |
| 2021 | 2021-12-31 | $2.3M | −$856,000 | −27.09% |
| 2020 | 2020-12-31 | $3.2M | $202,000 | +6.83% |
| 2019 | 2019-12-31 | $3.0M | $1.3M | +82.59% |
| 2018 | 2018-12-31 | $1.6M | −$169,000 | −9.45% |
| 2017 | 2017-12-31 | $1.8M | $579,000 | +47.85% |
| 2016 | 2016-12-31 | $1.2M | −$38,000 | −3.04% |
| 2015 | 2015-12-31 | $1.2M | $63,000 | +5.32% |
| 2014 | 2014-12-31 | $1.2M | −$269,000 | −18.50% |
| 2013 | 2013-12-31 | $1.5M | −$4,000 | −0.27% |
| 2012 | 2012-12-31 | $1.5M | −$9,000 | −0.61% |
| 2011 | 2011-12-31 | $1.5M | — | — |
Concord Medical Services Holdings stock-based compensation trends
Over the last five fiscal years, Concord Medical Services Holdings's stock-based compensation decreased from $1.8M to −$858,000, a change of −$2.6M.
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Concord Medical Services Holdings source filings ↗